MicroRNA-135a regulates NHE9 to inhibit proliferation and migration of glioblastoma cells.

Autor: Gomez Zubieta DM; Department of Natural Sciences, University of Michigan-Dearborn, 4901 Evergreen Road, SFC # 207, Dearborn, MI, 48128, USA., Hamood MA; Department of Natural Sciences, University of Michigan-Dearborn, 4901 Evergreen Road, SFC # 207, Dearborn, MI, 48128, USA., Beydoun R; Department of Natural Sciences, University of Michigan-Dearborn, 4901 Evergreen Road, SFC # 207, Dearborn, MI, 48128, USA., Pall AE; Department of Natural Sciences, University of Michigan-Dearborn, 4901 Evergreen Road, SFC # 207, Dearborn, MI, 48128, USA., Kondapalli KC; Department of Natural Sciences, University of Michigan-Dearborn, 4901 Evergreen Road, SFC # 207, Dearborn, MI, 48128, USA. kondap@umich.edu.
Jazyk: angličtina
Zdroj: Cell communication and signaling : CCS [Cell Commun Signal] 2017 Dec 21; Vol. 15 (1), pp. 55. Date of Electronic Publication: 2017 Dec 21.
DOI: 10.1186/s12964-017-0209-7
Abstrakt: Background: Glioblastoma multiformae (GBM) is the most aggressive type of malignant brain tumor with complex molecular profile. Overexpression of Na + /H + Exchanger isoform 9 (NHE9) promotes tumor progression and correlates positively with insensitivity to radiochemotherapy and poor prognosis. However, molecular mechanisms responsible for increase in NHE9 levels beyond a critical threshold have not been identified.
Methods: Bioinformatics analysis, luciferase reporter assays, real-time PCR and western blotting were conducted to examine the expression profiles and identify microRNAs (miRNA) that target NHE9. Cell proliferation and migration assays were conducted in U87 glioblastoma cells to determine the consequence of miRNA mediated targeting of NHE9. Endosomal pH measurements, immunofluorescence microscopy and surface biotinylation experiments were conducted to characterize the mechanistic basis of regulation.
Results: We show that microRNA 135a (miR-135a) targets NHE9 to downregulate its expression in U87 cells. MiR-135a levels are significantly lower in glioblastoma cells compared to normal brain tissue. Downregulation of NHE9 expression by miR-135a affects proliferative and migratory capacity of U87 cells. Selectively increasing NHE9 expression in these cells restored their ability to proliferate and migrate. We demonstrate that miR-135a takes a two-pronged approach affecting epidermal growth factor receptors (EGFRs) to suppress tumor cell growth and migration. EGFR activity is a potent stimulator of oncogenic signaling. While miR-135a targets EGFR transcripts to decrease the total number of receptors made, by targeting NHE9 it routes the few EGFRs made away from the plasma membrane to dampen oncogenic signaling. NHE9 is localized to sorting endosomes in glioblastoma cells where it alkalinizes the endosome lumen by leaking protons. Downregulation of NHE9 expression by miR-135a acidifies sorting endosomes limiting EGFR trafficking to the glioblastoma cell membrane.
Conclusions: We propose downregulation of miR-135a as a potential mechanism underlying the high NHE9 expression observed in subset of glioblastomas. Future studies should explore miR-135a as a potential therapeutic for glioblastomas with NHE9 overexpression.
Databáze: MEDLINE
Externí odkaz: